Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)
CNY 22.22
(10.0%)
CNY 22.22
(10.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -22.39 Million | -24.59 Million | 18.28 Million | 83.33 Million | 77.59 Million | 78.12 Million |
| Net Income | 8.27 Million | -76.54 Million | 53.31 Million | 96.87 Million | 102.83 Million | 71.08 Million |
| Depreciation & Amortization | 23.42 Million | 19.58 Million | 15.44 Million | 9.7 Million | 9.74 Million | 9.17 Million |
| Deferred income taxes | 1.74 Million | -15.51 Million | -6.63 Million | 732.4 Thousand | 181.13 Thousand | -570.75 Thousand |
| Stock-based compensation | - | -17.66 Million | 16.82 Million | -732.4 Thousand | -181.13 Thousand | - |
| Change in working capital | -69.27 Million | 28.29 Million | -76.74 Million | -25.8 Million | -18.6 Million | -4.99 Million |
| Other non-cash items | 129.56 Million | 4.07 Million | 26.27 Million | 2.57 Million | -16.39 Million | 2.86 Million |
| Investing Cash Flow | -27.13 Million | -24.83 Million | -96.73 Million | -83.05 Million | -57.1 Million | -72.76 Million |
| Investments in PPE | -30.73 Million | -24.16 Million | -39.6 Million | -35.63 Million | -58.32 Million | -61.58 Million |
| Acquisitions | 56.74 Thousand | 76.95 Thousand | -37.29 Million | 2.73 Million | 7.17 Million | -11.18 Million |
| Investment purchases | -173.5 Million | -3 Million | -22.5 Million | -52.4 Million | -6.6 Million | - |
| Sales/Maturities of investments | 177.03 Million | 259 Million | 129.09 Thousand | 751.05 Thousand | 113.39 Thousand | - |
| Other Investing Activities | -58.84 Thousand | -256.74 Million | 2.53 Million | 1.49 Million | 532.44 Thousand | 5000.00 |
| Financing Cash Flow | 1.67 Million | 23.91 Million | -35.84 Million | -32.32 Million | -36.07 Million | 260.7 Million |
| Debt repayment | -9.8 Million | -29.4 Million | -3.96 Million | -448 Thousand | - | - |
| Dividends payments | -1.32 Million | -633.57 Thousand | -31.51 Million | -32.32 Million | -32.32 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | -23.45 Million |
| Other Financing Activities | -8.12 Million | 53.95 Million | -4.33 Million | 448 Thousand | -3.75 Million | 260.7 Million |
| Accounts receivables | -56.04 Million | 9.1 Million | -47.61 Million | -33.95 Million | -42.98 Million | -17.63 Million |
| Accounts payables | -18.32 Million | 28.38 Million | 11.13 Million | 10.67 Million | 31.83 Million | - |
| Inventory | 5.09 Million | 6.31 Million | -33.63 Million | -3.26 Million | -7.63 Million | -1.05 Million |
| Other working capital | -16.58 Million | -15.51 Million | -6.63 Million | 732.4 Thousand | 181.13 Thousand | -3.93 Million |
| Cash at beginning of period | 249.25 Million | 274.26 Million | 388.55 Million | 420.59 Million | 436.13 Million | 169.82 Million |
| Cash at end of period | 200.89 Million | 248.75 Million | 274.26 Million | 388.55 Million | 420.59 Million | 436.13 Million |
| Capital Expenditure | -30.73 Million | -24.16 Million | -39.6 Million | -35.63 Million | -58.32 Million | -61.58 Million |
| Effect of forex changes on cash | - | 0.11 | 0.85 | 0.34 | 39.84 Thousand | 252.2 Thousand |
| Net cash flow / Change in cash | -48.35 Million | -25.51 Million | -114.29 Million | -32.03 Million | -15.54 Million | 266.31 Million |
| Free Cash Flow | -53.12 Million | -48.76 Million | -21.31 Million | 47.7 Million | 19.26 Million | 16.54 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.08 Million | 7.53 Million | 1.35 Million | 1.47 Million | 8.27 Million | 4.02 Million |
| Depreciation & Amortization | - | 6.6 Million | 6.6 Million | 5.76 Million | 23.42 Million | 5.76 Million |
| Deferred income taxes | - | - | - | - | 1.74 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 3.96 Million | - | -50.95 Million | -69.27 Million | 29.12 Million |
| Other non-cash items | -25.95 Million | 61.15 Million | -65.74 Million | 50.06 Million | 129.56 Million | -18.04 Million |
| Investing Cash Flow | -4.3 Million | 4.6 Million | -97.14 Million | 47.49 Million | -27.13 Million | 9.21 Million |
| Investments in PPE | -645.72 Thousand | -864.99 Thousand | -3.23 Million | -7.35 Million | -30.73 Million | -2.38 Million |
| Acquisitions | - | 4.47 Million | 90 Thousand | 1946.15 | 56.74 Thousand | 50 Thousand |
| Investment purchases | 89.2 Million | -93 Million | -2 Million | -172.5 Million | -173.5 Million | 82 Million |
| Sales/Maturities of investments | -1 Million | 2 Million | - | 165 Million | 177.03 Million | -7.96 Million |
| Other Investing Activities | -91.85 Million | 92 Million | -92 Million | 62.34 Million | -58.84 Thousand | -62.49 Million |
| Financing Cash Flow | -1.94 Million | -10.76 Million | 8.58 Million | -3.35 Million | 1.67 Million | -2.71 Million |
| Debt repayment | -9.2 Million | - | -10 Million | - | -9.8 Million | -9.9 Million |
| Dividends payments | - | -8.57 Million | -332.16 Thousand | -321.99 Thousand | -1.32 Million | -383.62 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -11.14 Million | -7.49 Million | -1.41 Million | -3.35 Million | -8.12 Million | 7.56 Million |
| Accounts receivables | - | 17.51 Million | - | -56.04 Million | -56.04 Million | 25.87 Million |
| Accounts payables | - | - | - | - | -18.32 Million | - |
| Inventory | - | -13.55 Million | - | 5.09 Million | 5.09 Million | 3.24 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 103.87 Million | 47.94 Million | 200.89 Million | 110.97 Million | 249.25 Million | 119.06 Million |
| Cash at end of period | 66.59 Million | 103.87 Million | 47.94 Million | 200.89 Million | 200.89 Million | 110.97 Million |
| Capital Expenditure | -645.72 Thousand | -864.99 Thousand | -3.23 Million | -7.35 Million | -30.73 Million | -2.38 Million |
| Effect of forex changes on cash | - | - | - | - | - | -573.65 Thousand |
| Net cash flow / Change in cash | -37.28 Million | 55.92 Million | -152.95 Million | 89.91 Million | -48.35 Million | -8.08 Million |
| Free Cash Flow | -31.68 Million | 61.22 Million | -67.62 Million | 38.42 Million | -53.12 Million | -16.39 Million |
ESLOF
002434
002265
300193
ADP
BSP